Confidence: 100%
B0FWVWGVHP
View on Amazon →SuppScoreLab compares supplement products for informational purposes. We do not sell products directly, and some links may take you to third-party retailers.
Decision summary
A middling option. It may be usable, but weaker dosing makes better alternatives worth comparing.
Best for
Buyers who want a solid pick and can tolerate a couple of trade-offs.
Consider another option if
You want fewer compromises on formulation quality.
Score breakdown
Tap a module to see what it measures. A 0 can reflect missing disclosure, not just a negative result.
Dosage quality
3.9/10Dosing looks weaker than ideal
Checks whether labeled ingredient amounts fall within clinically studied ranges (not just regulatory minimums). Low/0 can reflect under-dosing or missing amounts (e.g., proprietary blends).
Explore next
The formula stays relatively clean on excipients. The main limitation is that epa: below clinically studied range.
Strengths
Weaknesses
Final verdict
A middling option. It may be usable, but weaker dosing makes better alternatives worth comparing.
A closer look at the main ingredients, how they influence the score, and the supporting evidence when available. Tap any ingredient to expand.
ℹ At the minimum effective range, but below the optimal dose; evidence is strong
Dose meets the minimum effective range, but is below the optimal dose used for stronger effects. This is a limiting factor: Dose is below the ranges usually used for stronger effects. The declared form is not one of the better-absorbed options.
Scientific evidence
Yurko-Mauro et al. RCT DHA and memory in age-related decline
Alzheimer's & Dementia • 2010
PMID: 20439549.0
ℹ At the minimum effective range, but below the optimal dose; evidence is strong
Dose meets the minimum effective range, but is below the optimal dose used for stronger effects. This is a limiting factor: Dose is likely below clinically useful levels. The declared form is not one of the better-absorbed options.
Scientific evidence
Fortin et al. meta-analysis omega-3 and rheumatoid arthritis
Journal of Rheumatology • 2000
PMID: 12480795.0
Bhatt et al. REDUCE-IT trial EPA and cardiovascular events
New England Journal of Medicine • 2019
PMID: 31141425.0
Important label or formulation details that may affect how this product should be interpreted.
Epa dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Read our methodology overview to understand how SuppScoreLab combines multiple scientific dimensions into one practical score.
View methodology →This evaluation is based on the product label and declared Supplement Facts available at review time. It does not verify laboratory-tested composition, purity, or batch-level quality. This content is educational and not medical advice. Consult a qualified healthcare professional for personal health decisions. Affiliate disclosure: SuppScoreLab may earn a commission from qualifying Amazon links.
See the best Omega-3 supplements ranked with the same methodology, or keep exploring the database.
